본문바로가기
Language
Q
U
I
C
K

IR

SK bioscience is committed to establishing a corporate culture
and system for sustainable product development.

Financial Information

Balance Sheet

(Unit: million won)

Balance sheet - Sort, 1st period(2018.12.31), 2nd period(2019.12.31), 3rd period(2020.12.31), 4rd period(2021.12.31)
Sort 1st period (2018.07.01-2018.12.31) 2nd period (2019.01.01-2019.12.31) 3rd period (2020.01.01-2020.12.31) 4rd period (2021.01.01-2021.12.31)
Liquid assets 180,729 170,741 333,902 1,837,804
Cash and cash equivalents 4,489 14,380 24,972 98,028
Short-term financial investment 99,189 80,088 183,736 1,547,635
Receivables 43,472 32,429 45,838 48,134
Inventory assets 31,876 36,379 70,275 135,045
Other inventory assets 1,650 7,465 782 8,508
Contract asset 0 0 980 0
Derivative financial assets 53 0 128 451
Non-current assets 219,268 233,239 228,330 272,318
Long-term financial investment 10,985 10,597 0 21,609
Deposit 356 348 455 690
Tangible assets 172,831 182,477 180,992 210,264
Copy right assets 0 8,293 8,487 10,718
Intangible assets 21,839 19,479 17,858 17,061
Other liquid assets 85 85 95 91
Derivative financial assets 0 65 0 1,639
Deferred tax asset 13,172 11,895 20,443 10,241
Total 399,997 403,980 562,232 2,110,123

Liabilities

(Unit: million won)

Liabilities - Sort, 1st period(2018.12.31), 2nd period(2019.12.31), 3rd period(2020.12.31), 4rd period(2021.12.31)
Sort 1st period (2018.07.01-2018.12.31) 2nd period (2019.01.01-2019.12.31) 3rd period (2020.01.01-2020.12.31) 4rd period (2021.01.01-2021.12.31)
Liquid liabilities 50,610 45,509 108,640 459,952
Purchased and other liabilities 25,542 31,613 39,153 102,184
Liquidity bond 0 0 10,995 47,977
Long-term liquidity loan 11,250 0 0 11,671
Liquidity lease 161 1,351 1,614 2,309
Other liquidity bond 8,374 7,780 28,640 94,638
Liquidity contract liabilities 5,283 4,687 94,899 98,789
Derivative financial liabilities 0 0 75 894
Corporate tax liabilities
(Current period)
0 78 5,264 101,485
Non-current liabilities 130,142 125,737 117,802 48,858
Private bonds 92,196 93,473 80,473 35,502
Long-term loans 34,353 23,156 21,760 0
Lease 0 7,093 7,126 8,774
Defined-benefit liabilities 1,774 2,015 4,358 4,246
Derivative financial liabilities 1,819 0 3,617 0
Other non-current liabilities 0 0 468 335
Total 180,752 171,246 298,442 508,811

Capital

(Unit: million won)

Capital - Sort, 1st period(2018.12.31), 2nd period(2019.12.31), 3rd period(2020.12.31), 4rd period(2021.12.31)
Sort 1st period (2018.07.01-2018.12.31) 2nd period (2019.01.01-2019.12.31) 3rd period (2020.01.01-2020.12.31) 4rd period (2021.01.01-2021.12.31)
Gross capital 10,200 10,200 30,600 38,250
Capital surplus 201,219 201,219 180,518 1,157,063
Other capital 25 325 901 900
Accumulated income (1,242) (1,319) -1,465 (207)
Retained earnings 9,043 22,309 53,236 405,305
Total 219,245 232,734 263,790 1,601,311

Income Statement

(Unit: million won)

Income statement - Sort, 1st period(2018.07.01-2018.12.31), 2nd period(2019.01.01-2019.12.31), 3rd period(2020.01.01-2020.12.31), 4rd period(2021.01.01-2021.12.31)
Sort 1st period (2018.07.01-2018.12.31) 2nd period (2019.01.01-2019.12.31) 3rd period (2020.01.01-2020.12.31) 4rd period (2021.01.01-2021.12.31)
Sales profits 99,403 183,938 225,611 929,001
Sales costs 48,958 106,078 130,269 358,718
Sales total 50,445 77,860 95,342 570,283
Sales & maintenance costs 24,009 55,063 57,632 96,063
Profits 26,436 22,797 37,710 474,220
Other profits 99 144 3,742 5,159
Other expenses 12,937 1,934 1,909 2,849
Financial revenues 1,303 5,184 7,903 26,241
Financial expenses 2,807 7,706 10,153 31,643
Net income
(Including corporate tax)
12,094 18,485 37,293 471,128
Corporate tax 3,161 3,808 4,403 115,989
Net income (Current period) 8,933 14,677 32,890 355,139
Other comprehensive income (173) (1,489) -2,108 (1,813)
Other comprehensive income
(that is subsequently reclassified as profit or loss)
0 0 0 0
Derivative revenues (283) (77) -146 1,257
Other comprehensive income
(that is subsequently unclassified as profit or loss)
0 0 0 0
Remeasurement of defined expenses 110 (1,412) -1,962 (3,070)
Accumulated other comprehensive income 8,760 13,188 30,782 353,326
Basic profits / shares 149 240 537 4,844
Diluted EPS 0 0 533 4,810